Profil
Stephen A. Gorgol is currently the Chief Financial Officer, Secretary & Treasurer at BioVex, Inc. He previously held the same position at BioVex Group, Inc. and was the Vice President-Finance & Administration at uniQure, Inc. He also served as the Chief Financial & Accounting Officer at Replimune Group, Inc. Prior to these roles, he was the Chief Financial Officer at iVOW, Inc. from 1997 to 2004.
Mr. Gorgol received his undergraduate degree from Plymouth State University in 1980.
Postes actifs de Stephen A. Gorgol
| Sociétés | Poste | Début |
|---|---|---|
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Directeur Financier/CFO | 15/05/2009 |
Anciens postes connus de Stephen A. Gorgol
| Sociétés | Poste | Fin |
|---|---|---|
uniQure, Inc.
uniQure, Inc. BiotechnologyHealth Technology Provides research and development services of human gene based therapies | Corporate Officer/Principal | 01/05/2016 |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Directeur Financier/CFO | 01/01/2011 |
iVOW, Inc.
iVOW, Inc. Medical/Nursing ServicesHealth Services Provides services to physicians and hospitals involved in the surgical treatment of morbid obesity | Directeur Financier/CFO | 01/01/2004 |
| REPLIMUNE GROUP, INC. | Directeur Financier/CFO | 09/12/2019 |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases | Directeur Financier/CFO | - |
Formation de Stephen A. Gorgol
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
iVOW, Inc.
iVOW, Inc. Medical/Nursing ServicesHealth Services Provides services to physicians and hospitals involved in the surgical treatment of morbid obesity | Health Services |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases | Commercial Services |
Plymouth State University
Plymouth State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
uniQure, Inc.
uniQure, Inc. BiotechnologyHealth Technology Provides research and development services of human gene based therapies | Health Technology |
Replimune Group, Inc.
Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
















